Intellectual Property

Greenberg Traurig is extremely proud to represent Redhill Biopharma with the recent announcement of providing an initial update on the compassionate use program with its investigational drug, opaganib, in patients
Continue Reading Greenberg Traurig Is Proud to Represent Redhill Biopharma Treating COVID-19 Patient with Opaganib in Israel Under Compassionate Use

Greenberg Traurig was pleased to sponsor the Annual OurCrowd Global Investors Summit for the fourth consecutive year. The event, hosted in Jerusalem, traditionally brings together thousands of entrepreneurs, startup companies
Continue Reading Greenberg Traurig Sponsors 2019 OurCrowd Global Investors Summit

Greenberg Traurig (Tel Aviv) attorney Devora Snyder delivered the keynote address at Google Israel’s recent conference, “Aging 2.0: Using Sensors for Early Detection of Age-Related Diseases.” Devora, whose
Continue Reading Devora Snyder Discusses Compliance at Google Israel Event

In our Feb. 9th blog post, we highlighted some of the amazing technology being used at the 2018 Winter Olympics in Pyeongchang, South Korea. While awe-inspiring, the use of these technologies can give rise to legal challenges that may need consideration.
Continue Reading Technology’s Legal Road to the 2018 Winter Olympics – and Beyond